ARBM 301
Alternative Names: ARBM-301Latest Information Update: 03 Aug 2022
At a glance
- Originator ArborMed
- Class
- Mechanism of Action Anion transport protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Sensorineural hearing loss
Most Recent Events
- 13 Jul 2022 Preclinical trials in Sensorineural hearing loss in South Korea (Intrapleural) (ArborMed pipeline, July 2022)